The Glucose Tolerance Test Study

Phase 4

Completed

• Conditions: Anti-inflammatory effect of insulin after Oral versus intravenous glucose in overweight individuals.; Overweight/obesity; Metabolic and Endocrine - Normal metabolism and endocrine development and function

• Registration Number: ACTRN12612000491864
• Lead Sponsor: niverstiy of otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

BMI > 27kg/m2 , have no ongoing health problems, not have diabetes, take no medication.

Exclusion Criteria

Smoking, diabetes. Taking medications. BMI < 27kg/m2

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma level of IL-6 will be measured at 5 points after the glucose and water are given.[These levels will be measured in blood samples taken at 0, 30, 60, 90 and 120 minutes.]

Secondary Outcome Measures

Name	Time	Method
We will expand available information on the acute anti-inflammatory effect of insulin which may be important in limiting the inflammatory effect of food by measuring changes in plasma IL-6 levels.[proposed publication of results in peer reviewed journals 2012]